Pharvaris
PHVS
52 hedge funds and large institutions have $706M invested in Pharvaris in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 5 closing their positions.
7% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 14
0.55% more ownership
Funds ownership: 82.66% → 83.21% (+0.55%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
4% less funds holding
Funds holding: 54 → 52 (-2)
18% less capital invested
Capital invested by funds: $856M → $706M (-$150M)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$3.77M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$2.4M |
| 3 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
+$2.14M |
| 4 |
Morgan Stanley
New York
|
+$816K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$753K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$2.56M |
| 2 |
VA
VR Adviser
New York
|
-$1.81M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$853K |
| 4 |
Goldman Sachs
New York
|
-$848K |
| 5 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
-$653K |
PHVS Hedge Fund Activity: Q1 2025 in Review
52 of the 7,475 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q1 2025, worth a combined $706M — down 18% from $856M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PHVS and 3 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 15 added.
The largest buyer was Rosalind Advisors, opening a new position worth an estimated $3.77M. The largest seller was Rock Springs Capital Management, cutting an estimated $2.56M.
- 52 institutional investors held Pharvaris (PHVS) as of Q1 2025, down from 54 in Q4 2024.
- Funds reported $706M of Pharvaris stock for Q1 2025, down 18% quarter-over-quarter.
- 3 funds opened new Pharvaris positions in Q1 2025 and 5 closed out, a net change of -2 holders.
- The largest Pharvaris buyer in Q1 2025 was Rosalind Advisors, an estimated $3.77M added.
- The largest Pharvaris seller in Q1 2025 was Rock Springs Capital Management, an estimated $2.56M sold.
Based on aggregated 13F filings for Q1 2025.